Cancer is not a risk factor for severe COVID-19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities.

Filiaciones

Velasco Puyó P:

Pediatric Oncology and Hematology Department, Vall d'Hebron Barcelona Hospital, Barcelona, Spain

Tagarro A:

Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain

Department of Pediatrics, Infanta Sofía University Hospital, Fundación para la Investigación Biomédica e Innovación Hospital Universitario Infanta Sofía y Hospital del Henares (FIIB HUIS HHEN), Madrid, Spain

Universidad Europea de Madrid, Madrid, Spain

Garcia-Obregon S:

BioBizkaia Health Research Institute, Pediatric Oncology Group, Barakaldo, Spain

UPV/EHU, Physiology Department, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Leioa, Spain

Villate O:

BioBizkaia Health Research Institute, Pediatric Oncology Group, Barakaldo, Spain

Moraleda C:

Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain

Pediatric Infectious Disease Unit, Hospital Universitario 12 de Octubre, Madrid, Spain

Huerta Aragonés J:

Paediatrics Department, Paediatric and Adolescent Haematology and Oncology Section, Hospital Materno-Infantil del Complejo Hospitalario General Universitario Gregorio Marañón, Madrid, Spain

Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain

Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Bardón Cancho EJ:

Paediatrics Department, Paediatric and Adolescent Haematology and Oncology Section, Hospital Materno-Infantil del Complejo Hospitalario General Universitario Gregorio Marañón, Madrid, Spain

Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain

Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

Faura Morros A:

Pediatric Oncology and Hematology Unit, Hospital Sant Joan de Déu, Barcelona, Spain

Galán-Gómez V:

Pediatric Oncology and Hematology Department, Hospital Infantil Universitario La Paz, Madrid, Spain

Escobar Fernández L:

Pediatric Oncology and Hematology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain

Lendinez-Molinos F:

Pediatric Oncology and Hematology Department, Hospital Infantil Infanta Leonor, Almería, Spain

Herrero Velasco B:

Pediatric Oncology and Hematology Unit, Hospital Infantil Universitario del Niño Jesús, Madrid, Spain

Ureña Horno L:

Hospital Doctor Balmis de Alicante, Alicante, Spain

Domínguez-Pinilla N:

Pediatric Oncology Unit, Complejo Hospitalario de Toledo, Toledo, Spain

i+12 Research Institute, Hospital 12 de Octubre, Madrid, Spain

Pascual Gazquez JF:

Pediatric Oncology and Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain

Nova Lozano C:

Hospital Clínico Universitario Valencia, Valencia, Spain

Osuna-Marco M:

Pediatric Oncology and Hematology Unit, HM Hospitals, Madrid, Spain

Marín-Cruz I:

Paediatric Infectious Diseases, Rheumatology and Immunology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain

Congenital Alterations of Immunity Group, Infectious Diseases and Immune System Area, Instituto de Biomedicina de Sevilla, Sevilla, Spain

Gomez Pastrana I:

Pediatric Infectious Disease Unit, Hospital Universitario 12 de Octubre, Madrid, Spain

Garcia de Andoin Barandiaran N:

Pediatric Oncology and Hematology Unit, Donostia University Hospital, San Sebastián, Spain

Biogipuzkoa Health Research Institute, Pediatric Group, Paseo Dr. Begiristain, San Sebastián, Spain

UPV/EHU, Pediatric Department, Paseo Dr. J. Beguiristain, Universidad del País Vasco/Euskal Herriko Unibertsitatea, San Sebastian, Spain

Gallego Mingo N:

Paediatrics Department, Hospital Universitario Son Espases, Mallorca, Spain

Portugal Rodríguez R:

Pediatric Oncology and Hematology Department, Hospital Universitario de Burgos, Burgos, Spain

Cañete A:

Pediatric Oncology and Hematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain

Pareja León M:

Paediatrics Department, Hospital General de Albacete, Albacete, Spain

Castrillo Bustamante S:

Paediatrics Department, Complejo Asistencial de Segovia, Segovia, Spain

Tallón García M:

Hospital Álvaro Cunqueiro, Vigo, Spain

Gónzalez-Prieto A:

Pediatric Oncology and Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain

Solé-Rodríguez M:

Hospital Universitario Juan Ramón Jiménez, Huelva, Spain

González Cruz M:

Paediatrics Department, Hospital Universitario de Canarias, Tenerife, Spain

Soriano-Arandes A:

Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Hospital Vall d'Hebron, Barcelona, Catalonia, Spain

Mota M:

Unit of Statistics and Bioinformatics (UEB), Vall d'Hebron Research Institute (VHIR), Barcelona, Spain

Pérez-Hoyos S:

Unit of Statistics and Bioinformatics (UEB), Vall d'Hebron Research Institute (VHIR), Barcelona, Spain

Moreno L:

Pediatric Oncology and Hematology Department, Vall d'Hebron Barcelona Hospital, Barcelona, Spain

Astigarraga I:

BioBizkaia Health Research Institute, Pediatric Oncology Group, Barakaldo, Spain

Department of Pediatrics, Hospital Universitario Cruces, Barakaldo, Spain

UPV/EHU, Department of Pediatrics, Universidad del País Vasco/Euskal Herriko Unibertsitatea, Barakaldo, Spain